Theraclion SA (TCLIF)
OTCMKTS
· Delayed Price · Currency is USD
0.320
+0.320 (159,900.00%)
At close: Aug 26, 2024
Theraclion Statistics
Total Valuation
Theraclion has a market cap or net worth of 33.34 million. The enterprise value is 37.31 million.
| Market Cap | 33.34M |
| Enterprise Value | 37.31M |
Important Dates
The next estimated earnings date is Tuesday, December 23, 2025.
| Earnings Date | Dec 23, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 45.68M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 18.71% |
| Owned by Institutions (%) | 6.93% |
| Float | 24.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.15 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.05 |
| EV / Sales | 17.11 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -24.82 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 68,783 |
| Profits Per Employee | -192,752 |
| Employee Count | 32 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.10M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -0.12 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 2,367 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Theraclion had revenue of 2.20 million and -6.17 million in losses.
| Revenue | 2.20M |
| Gross Profit | -3.88M |
| Operating Income | -7.01M |
| Pretax Income | -7.26M |
| Net Income | -6.17M |
| EBITDA | -6.52M |
| EBIT | -7.01M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity (Book Value) | n/a |
| Book Value Per Share | n/a |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is -176.20%, with operating and profit margins of -318.54% and -280.23%.
| Gross Margin | -176.20% |
| Operating Margin | -318.54% |
| Pretax Margin | -330.05% |
| Profit Margin | -280.23% |
| EBITDA Margin | -296.30% |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Theraclion does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -18.50% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |